Gut Brain Axis Therapeutics is a biotechnology company that offers treatment for Autism Spectrum Disorder with microbial transplant therapy.
Gut Brain Axis Therapeutics has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Gut Brain Axis Therapeutics is headquartered in Tempe, United States.
Gut Brain Axis Therapeutics is a biotechnology company that offers treatment for Autism Spectrum Disorder with microbial transplant therapy.
Gut Brain Axis Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gut Brain Axis Therapeutics — Funding & Investors." VCBacked, November 6, 2025, https://www.vcbacked.co/company/gut-brain-axis-therapeutics. Accessed September 15, 2026.
VCBacked. (2025). Gut Brain Axis Therapeutics — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/gut-brain-axis-therapeutics
{{cite web |title=Gut Brain Axis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/gut-brain-axis-therapeutics |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated